Edwards Lifesciences Return on Tangible Equity 2010-2025 | EW
Current and historical return on tangible equity values for Edwards Lifesciences (EW) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Edwards Lifesciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $4.18B | $7.24B | 61.18% |
| 2024-12-31 | $4.18B | $7.11B | 65.28% |
| 2024-09-30 | $4.16B | $7.05B | 70.35% |
| 2024-06-30 | $1.47B | $5.94B | 27.28% |
| 2024-03-31 | $1.41B | $5.49B | 27.76% |
| 2023-12-31 | $1.40B | $5.18B | 29.23% |
| 2023-09-30 | $1.43B | $5.00B | 31.14% |
| 2023-06-30 | $1.39B | $4.72B | 30.59% |
| 2023-03-31 | $1.49B | $4.31B | 33.24% |
| 2022-12-31 | $1.52B | $4.36B | 33.89% |
| 2022-09-30 | $1.46B | $4.79B | 32.51% |
| 2022-06-30 | $1.46B | $4.46B | 33.83% |
| 2022-03-31 | $1.54B | $4.36B | 37.58% |
| 2021-12-31 | $1.50B | $4.34B | 39.60% |
| 2021-09-30 | $1.48B | $4.05B | 42.51% |
| 2021-06-30 | $1.46B | $3.64B | 46.56% |
| 2021-03-31 | $0.85B | $3.16B | 30.20% |
| 2020-12-31 | $0.82B | $3.07B | 31.34% |
| 2020-09-30 | $0.79B | $2.71B | 31.48% |
| 2020-06-30 | $0.74B | $2.34B | 30.81% |
| 2020-03-31 | $1.11B | $2.40B | 47.85% |
| 2019-12-31 | $1.05B | $2.64B | 47.24% |
| 2019-09-30 | $0.77B | $2.28B | 39.16% |
| 2019-06-30 | $0.73B | $1.94B | 39.19% |
| 2019-03-31 | $0.77B | $2.00B | 43.53% |
| 2018-12-31 | $0.72B | $1.69B | 43.45% |
| 2018-09-30 | $0.71B | $1.77B | 45.03% |
| 2018-06-30 | $0.66B | $1.58B | 41.52% |
| 2018-03-31 | $0.56B | $1.62B | 35.47% |
| 2017-12-31 | $0.58B | $1.36B | 38.29% |
| 2017-09-30 | $0.75B | $1.77B | 45.73% |
| 2017-06-30 | $0.72B | $1.57B | 43.37% |
| 2017-03-31 | $0.66B | $1.40B | 39.39% |
| 2016-12-31 | $0.57B | $1.79B | 33.82% |
| 2016-09-30 | $0.55B | $1.86B | 33.34% |
| 2016-06-30 | $0.53B | $1.63B | 33.27% |
| 2016-03-31 | $0.52B | $1.47B | 31.09% |
| 2015-12-31 | $0.50B | $1.67B | 28.34% |
| 2015-09-30 | $0.46B | $1.59B | 26.05% |
| 2015-06-30 | $0.44B | $1.90B | 24.60% |
| 2015-03-31 | $0.87B | $1.83B | 51.74% |
| 2014-12-31 | $0.81B | $1.79B | 55.40% |
| 2014-09-30 | $0.78B | $1.64B | 59.88% |
| 2014-06-30 | $0.76B | $1.50B | 66.84% |
| 2014-03-31 | $0.31B | $0.92B | 29.22% |
| 2013-12-31 | $0.39B | $1.13B | 35.39% |
| 2013-09-30 | $0.40B | $0.99B | 37.50% |
| 2013-06-30 | $0.40B | $1.13B | 35.63% |
| 2013-03-31 | $0.37B | $1.15B | 34.23% |
| 2012-12-31 | $0.29B | $1.03B | 28.03% |
| 2012-09-30 | $0.27B | $1.13B | 26.20% |
| 2012-06-30 | $0.25B | $1.02B | 25.74% |
| 2012-03-31 | $0.24B | $0.98B | 25.10% |
| 2011-12-31 | $0.24B | $0.92B | 25.28% |
| 2011-09-30 | $0.24B | $0.94B | 25.46% |
| 2011-06-30 | $0.24B | $0.96B | 25.63% |
| 2011-03-31 | $0.24B | $0.93B | 27.38% |
| 2010-12-31 | $0.22B | $0.93B | 26.92% |
| 2010-09-30 | $0.20B | $0.85B | 26.20% |
| 2010-06-30 | $0.23B | $0.73B | 31.22% |
| 2010-03-31 | $0.22B | $0.75B | 31.27% |
| 2009-12-31 | $0.23B | $0.76B | 35.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.151B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $186.962B | 81.89 |
| Thermo Fisher Scientific (TMO) | United States | $155.018B | 18.75 |
| Alcon (ALC) | Switzerland | $43.193B | 29.19 |
| IDEXX Laboratories (IDXX) | United States | $42.656B | 49.02 |
| DexCom (DXCM) | United States | $33.204B | 51.32 |
| IQVIA Holdings (IQV) | United States | $27.457B | 15.38 |
| Mettler-Toledo (MTD) | United States | $24.791B | 29.48 |
| STERIS (STE) | Ireland | $23.645B | 26.04 |
| Waters (WAT) | United States | $20.829B | 29.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.814B | 0.00 |
| Hologic (HOLX) | United States | $14.322B | 15.56 |
| Sysmex ADR (SSMXY) | Japan | $10.695B | 30.34 |
| Penumbra (PEN) | United States | $9.806B | 76.97 |
| Masimo (MASI) | United States | $9.179B | 33.86 |
| Globus Medical (GMED) | United States | $7.878B | 18.77 |
| Glaukos (GKOS) | United States | $5.675B | 0.00 |
| Teleflex (TFX) | United States | $5.265B | 8.69 |
| TransMedics (TMDX) | United States | $4.349B | 94.54 |
| Integer Holdings (ITGR) | United States | $4.215B | 22.08 |
| PROCEPT BioRobotics (PRCT) | United States | $3.221B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.501B | 14.89 |
| Nihon Kohden (NHNKY) | Japan | $2.156B | 24.73 |
| Veracyte (VCYT) | United States | $2.071B | 29.07 |
| Elekta AB (EKTAY) | Sweden | $1.965B | 17.67 |
| Alphatec Holdings (ATEC) | United States | $1.643B | 0.00 |
| Artivion (AORT) | United States | $1.307B | 122.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.294B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.030B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.768B | 38.97 |
| SiBone (SIBN) | United States | $0.764B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.83 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.535B | 12.53 |
| OrthoPediatrics (KIDS) | United States | $0.524B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.485B | 0.00 |
| AxoGen (AXGN) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.458B | 12.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.426B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.375B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.53 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EnVVeno Medical (NVNO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.85 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |